212 related articles for article (PubMed ID: 28719662)
1. The GalNAc-T Activation Pathway (GALA) is not a general mechanism for regulating mucin-type O-glycosylation.
Herbomel GG; Rojas RE; Tran DT; Ajinkya M; Beck L; Tabak LA
PLoS One; 2017; 12(7):e0179241. PubMed ID: 28719662
[TBL] [Abstract][Full Text] [Related]
2. Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes.
Gill DJ; Chia J; Senewiratne J; Bard F
J Cell Biol; 2010 May; 189(5):843-58. PubMed ID: 20498016
[TBL] [Abstract][Full Text] [Related]
3. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Casaravilla C; Freire T; Malgor R; Medeiros A; Osinaga E; Carmona C
J Parasitol; 2003 Aug; 89(4):709-14. PubMed ID: 14533679
[TBL] [Abstract][Full Text] [Related]
4. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
[TBL] [Abstract][Full Text] [Related]
5. Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus.
Röttger S; White J; Wandall HH; Olivo JC; Stark A; Bennett EP; Whitehouse C; Berger EG; Clausen H; Nilsson T
J Cell Sci; 1998 Jan; 111 ( Pt 1)():45-60. PubMed ID: 9394011
[TBL] [Abstract][Full Text] [Related]
6. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
7. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.
Zhang Y; Iwasaki H; Wang H; Kudo T; Kalka TB; Hennet T; Kubota T; Cheng L; Inaba N; Gotoh M; Togayachi A; Guo J; Hisatomi H; Nakajima K; Nishihara S; Nakamura M; Marth JD; Narimatsu H
J Biol Chem; 2003 Jan; 278(1):573-84. PubMed ID: 12407114
[TBL] [Abstract][Full Text] [Related]
9. The GalNAc-T Activation (GALA) Pathway: Drivers and markers.
Chia J; Tay F; Bard F
PLoS One; 2019; 14(3):e0214118. PubMed ID: 30889231
[TBL] [Abstract][Full Text] [Related]
10. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Freire T; Casaravilla C; Carmona C; Osinaga E
Int J Parasitol; 2003 Jan; 33(1):47-56. PubMed ID: 12547345
[TBL] [Abstract][Full Text] [Related]
11. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
[TBL] [Abstract][Full Text] [Related]
12. Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.
Ballard CJ; Paserba MR; Paul Daniel EJ; Hurtado-Guerrero R; Gerken TA
Glycobiology; 2023 Oct; 33(10):817-836. PubMed ID: 37555669
[TBL] [Abstract][Full Text] [Related]
13. Members of the GalNAc-T family of enzymes utilize distinct Golgi localization mechanisms.
Becker JL; Tran DT; Tabak LA
Glycobiology; 2018 Nov; 28(11):841-848. PubMed ID: 30084948
[TBL] [Abstract][Full Text] [Related]
14. Sialyl-Tn antigen expression and O-linked GalNAc-Thr synthesis by Trypanosoma cruzi.
Freire T; Robello C; Soulé S; Ferreira F; Osinaga E
Biochem Biophys Res Commun; 2003 Dec; 312(4):1309-16. PubMed ID: 14652017
[TBL] [Abstract][Full Text] [Related]
15. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2.
Perrine CL; Ganguli A; Wu P; Bertozzi CR; Fritz TA; Raman J; Tabak LA; Gerken TA
J Biol Chem; 2009 Jul; 284(30):20387-97. PubMed ID: 19460755
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
[TBL] [Abstract][Full Text] [Related]
17. An unusual dual sugar-binding lectin domain controls the substrate specificity of a mucin-type O-glycosyltransferase.
Collette AM; Hassan SA; Schmidt SI; Lara AJ; Yang W; Samara NL
Sci Adv; 2024 Mar; 10(9):eadj8829. PubMed ID: 38416819
[TBL] [Abstract][Full Text] [Related]
18. Polypeptide N-acetylgalactosaminyltransferase 18 retains in endoplasmic reticulum depending on its luminal regions interacting with ER resident UGGT1, PLOD3 and LPCAT1.
Jia W; Zou X; Xu Z; Bai L; Shan A; Li Y; Shi J; Yang F; Ding C; Narimatsu H; Zhang Y
Glycobiology; 2021 Sep; 31(8):947-958. PubMed ID: 33909026
[TBL] [Abstract][Full Text] [Related]
19. Polypeptide N-acetylgalactosaminyltransferase 18 non-catalytically regulates the ER homeostasis and O-glycosylation.
Shan A; Lu J; Xu Z; Li X; Xu Y; Li W; Liu F; Yang F; Sato T; Narimatsu H; Zhang Y
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):870-882. PubMed ID: 30797803
[TBL] [Abstract][Full Text] [Related]
20. Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
Kato K; Takeuchi H; Kanoh A; Miyahara N; Nemoto-Sasaki Y; Morimoto-Tomita M; Matsubara A; Ohashi Y; Waki M; Usami K; Mandel U; Clausen H; Higashi N; Irimura T
Glycoconj J; 2010 Feb; 27(2):267-76. PubMed ID: 20077002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
